An observational study in Sex Chromosome Disorders, sponsored by University of Aarhus. Enrolling by invitation at 1 site in Denmark. Open to participants aged 11 Weeks to 22 Weeks. Per ClinicalTrials.gov, last updated 2026-01-08.
Sponsored by University of Aarhus · Observational
Among 13 studies in Turner Syndrome by University of Aarhus — 5 open to participants now, 5 under way, none of them phase 3. Turner Syndrome · University of Aarhus.
Among the 13 studies in Turner Syndrome by University of Aarhus, this one is the 4th largest by planned enrollment of the 11 observational ones, is one of 3 that started in 2024, is one of 7 of another kind, and was the 12th registered.
125 studies on the registry are indexed under Turner Syndrome; 33 are open to participants now.
This study's planned enrollment of 120 is below the median of 164 across 70 observational studies indexed under Turner Syndrome.
Browse Turner Syndrome studies →5 of the 13 studies in Turner Syndrome by University of Aarhus are open now, in 1 country. Each count lists the studies.
Of the 25 Turner Syndrome studies recruiting now, 8 (32%) set no upper age limit and 14 (56%) stop at 75 or younger; 15 take children under 18; 5 take healthy volunteers.
This study: 11 Weeks to 22 Weeks · all sexes · no healthy volunteers.
The full table on the hub →13 studies; the count open now beside each. This study's row is marked.
First in 1994; this study’s year is marked. 3 started in 2024.
Median enrollment 58 across the 2 interventional studies, 106 across the 11 observational. Of the 4 that completed or were terminated, 0 (0%) have results posted.
University of Aarhus is the lead sponsor of 1,300 studies on the registry; 189 are open to participants now.
1 of the studies in Turner Syndrome by University of Aarhus that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06325618University of AarhusLymphedema, Low-grade Inflammation and the Vasculature in Turner Syndrome | 2027-08 |
Among the 13 studies in Turner Syndrome by University of Aarhus, from their registry updates:
Nothing recorded among them since 2026-09-25.
To conduct a comprehensive clinical investigation of electively aborted fetuses with sex chromosome disorders and their placentas, in parallel with analyses of epigenetic alterations and changes in gene expression in these fetuses and their placentas, with the aims to:
Recruitent of cases will take place at obstetric departments and departments of clinical genetics throughout Denmark.
Recruitment of controls will take place at obstetric departments in the Central Denmark Region.
Inclusion criteria cases:
Inclusion criteria cases:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
DNA methylation profile
DNA methylation of placenta DNA methylation across fetal tissues
Time frame: 5 years
Gene expression profile
RNA expression of placenta RNA expression across fetal tissue
Time frame: 5 years
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.